Results for hipereozinofilic translation from Romanian to English

cauza sindromului hipereozinofilic este necunoscută.
the cause of hypereosinophilic syndrome is unknown.

sindromul churg-strauss şi sindromul hipereozinofilic
churg-strauss syndrome and hypereosinophilic syndrome

26 august 2005), aici (hes - sindromul hipereozinofilic şi lec:
26 august 2005), here (hes and cel:

sindromul hipereozinofilic (she) şi/sau leucemia eozinofilică cronică (lec).
hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel).

s-au observat sindromul churg-strauss şi sindromul hipereozinofilic la pacienţii trataţi cu xolair.
churg-strauss and hypereosinophilic syndrome have been observed in patients treated with xolair.

s-au observat sindromul churg-strauss şi sindromul hipereozinofilic la pacienţii cu astm alergic, trataţi cu xolair.
churg-strauss and hypereosinophilic syndrome have been observed in allergic asthma patients treated with xolair.

la pacienţii cu sindrom hipereozinofilic (she) şi afectare cardiacă, au fost asociate cazuri izolate de şoc cardiogen/ disfuncţie ventriculară stângă cu iniţierea tratamentului cu imatinib.
in patients with hypereosinophilic syndrome (hes) and cardiac involvement, isolated cases of cardiogenic shock/ left ventricular dysfunction have been associated with the initiation of imatinib therapy.

neutropenie este necesară prudenţă la pacienţii cu valori scăzute ale numărului de leucocite şi/ sau de neutrofile, indiferent de cauză, la pacienţii trataţi cu medicamente cunoscute că determină neutropenie, la pacienţii cu antecedente de toxicitate/ deprimare medulară determinate de medicamente, la pacienţii cu deprimare medulară provocată de boli concomitente, radioterapie sau chimioterapie şi la pacienţii cu hipereozinofilie sau cu boli mieloproliferative.
18 caution should be exercised in patients with low leukocyte and/ or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of drug-induced bone marrow depression/ toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease.